Page last updated: 2024-10-29

ketamine and Parotid Neoplasms

ketamine has been researched along with Parotid Neoplasms in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Parotid Neoplasms: Tumors or cancer of the PAROTID GLAND.

Research Excerpts

ExcerptRelevanceReference
"Total intravenous anesthesia with propofol, fentanyl and ketamine (PFK) was given to two patients complicated with myotonic dystrophy."3.70[Total intravenous anesthesia for two patients complicated with myotonic dystrophy]. ( Kubota, T; Maeda, A; Matsuki, A; Miyata, A; Otomo, N; Yasuda, T, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yasuda, T1
Otomo, N1
Matsuki, A1
Kubota, T1
Miyata, A1
Maeda, A1

Other Studies

1 other study available for ketamine and Parotid Neoplasms

ArticleYear
[Total intravenous anesthesia for two patients complicated with myotonic dystrophy].
    Masui. The Japanese journal of anesthesiology, 1999, Volume: 48, Issue:2

    Topics: Adult; Anesthesia, Intravenous; Anesthetics, Combined; Anesthetics, Intravenous; Female; Fentanyl; H

1999